Medtronic plc — Director's Dealing 2022

Aug 3, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2022-08-01

Reporting Person: PARKHILL KAREN L (EVP & Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-01	Ordinary Shares	A	10744	—	Acquired	30962	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-01	Performance Share Units	$	A	26859	Acquired		Performance Share Units (26859)	Direct
2022-08-01	Stock Option (Right to Buy)	$93.08	A	84905	Acquired	2032-08-01	Ordinary Shares (84905)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	49859	Indirect
Ordinary Shares	843	Indirect
Ordinary Shares	843	Indirect
Ordinary Shares	843	Indirect

Footnotes

F1: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.

F2: These shares are held in the Jeffrey S. Parkhill 2021 Irrevocable Trust, of which the insider is the trustee and a beneficiary.

F3: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

F4: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 26,859 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

F5: Vests on August 1, 2025.

F6: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.